responderede eller var intolerante over for infliximab, randomiseret til at modtage enten 160 mg Trudexa i uge 0 og 80 mg i uge 2 eller placebo i uge 0 og 2.
response or were intolerant to infliximab were randomised to receive either 160 mg Trudexa at week 0 and 80 mg at week 2 or placebo at weeks 0 and 2.